183 related articles for article (PubMed ID: 35256687)
1. Nectin cell adhesion molecule 4 regulates angiogenesis through Src signaling and serves as a novel therapeutic target in angiosarcoma.
Tanaka Y; Murata M; Tanegashima K; Oda Y; Ito T
Sci Rep; 2022 Mar; 12(1):4031. PubMed ID: 35256687
[TBL] [Abstract][Full Text] [Related]
2. NECTIN4: A Novel Therapeutic Target for Melanoma.
Tanaka Y; Murata M; Shen CH; Furue M; Ito T
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33478111
[TBL] [Abstract][Full Text] [Related]
3. NECTIN4-targeted antibody-drug conjugate is a potential therapeutic option for extramammary Paget disease.
Tanaka Y; Ito T; Murata M; Tanegashima K; Kaku-Ito Y; Nakahara T
Exp Dermatol; 2024 Mar; 33(3):e15049. PubMed ID: 38509717
[TBL] [Abstract][Full Text] [Related]
4. Nectin Cell Adhesion Molecule 4 (NECTIN4) Expression in Cutaneous Squamous Cell Carcinoma: A New Therapeutic Target?
Tanaka Y; Murata M; Oda Y; Furue M; Ito T
Biomedicines; 2021 Mar; 9(4):. PubMed ID: 33808400
[TBL] [Abstract][Full Text] [Related]
5. Nectin4/PRR4, a new afadin-associated member of the nectin family that trans-interacts with nectin1/PRR1 through V domain interaction.
Reymond N; Fabre S; Lecocq E; Adelaïde J; Dubreuil P; Lopez M
J Biol Chem; 2001 Nov; 276(46):43205-15. PubMed ID: 11544254
[TBL] [Abstract][Full Text] [Related]
6. Role of Nectin‑4 protein in cancer (Review).
Liu Y; Han X; Li L; Zhang Y; Huang X; Li G; Xu C; Yin M; Zhou P; Shi F; Liu X; Zhang Y; Wang G
Int J Oncol; 2021 Nov; 59(5):. PubMed ID: 34664682
[TBL] [Abstract][Full Text] [Related]
7. NECTIN4 Expression in Extramammary Paget's Disease: Implication of a New Therapeutic Target.
Murata M; Ito T; Tanaka Y; Kaku-Ito Y; Furue M
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824340
[TBL] [Abstract][Full Text] [Related]
8. NECTIN4 expression in sebaceous and sweat gland carcinoma.
Ito T; Hashimoto H; Tanaka Y; Tanegashima K; Murata M; Oda Y; Kaku-Ito Y
Eur J Dermatol; 2022 Apr; 32(2):181-186. PubMed ID: 35866909
[TBL] [Abstract][Full Text] [Related]
9. Prominent role of the Ig-like V domain in trans-interactions of nectins. Nectin3 and nectin 4 bind to the predicted C-C'-C"-D beta-strands of the nectin1 V domain.
Fabre S; Reymond N; Cocchi F; Menotti L; Dubreuil P; Campadelli-Fiume G; Lopez M
J Biol Chem; 2002 Jul; 277(30):27006-13. PubMed ID: 12011057
[TBL] [Abstract][Full Text] [Related]
10. Nectin4 is a potential therapeutic target for asthma.
Lee PH; Choi SM; An MH; Hwang DY; Park S; Baek AR; Jang AS
Front Immunol; 2022; 13():1049900. PubMed ID: 36457999
[TBL] [Abstract][Full Text] [Related]
11. Development of Nectin4/FAP-targeted CAR-T cells secreting IL-7, CCL19, and IL-12 for malignant solid tumors.
Li F; Zhao S; Wei C; Hu Y; Xu T; Xin X; Zhu T; Shang L; Ke S; Zhou J; Xu X; Gao Y; Zhao A; Gao J
Front Immunol; 2022; 13():958082. PubMed ID: 36479116
[TBL] [Abstract][Full Text] [Related]
12. Serum nectin-2 and nectin-4 are diagnostic in lung cancer: which is superior?
Erturk K; Karaman S; Dagoglu N; Serilmez M; Duranyildiz D; Tas F
Wien Klin Wochenschr; 2019 Sep; 131(17-18):419-426. PubMed ID: 31440821
[TBL] [Abstract][Full Text] [Related]
13. Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E-based Antibody-Drug Conjugate for Treatment of Nectin-4-expressing Cancers.
Zhou W; Fang P; Yu D; Ren H; You M; Yin L; Mei F; Zhu H; Wang Z; Xu H; Cao Y; Sun X; Xu X; Bi J; Wang J; Ma L; Wang X; Chen L; Zhang Y; Cen X; Zhu X; Lou L; Liu D; Tan X; Yang J; Meng T; Shen J
Mol Cancer Ther; 2023 Aug; 22(8):913-925. PubMed ID: 37196158
[TBL] [Abstract][Full Text] [Related]
14. The significance of tumor cells-derived MFG-E8 in tumor growth of angiosarcoma.
Fujiwara C; Motegi SI; Ohira A; Yamaguchi S; Sekiguchi A; Yasuda M; Nakamura H; Makiguchi T; Yokoo S; Hoshina D; Abe R; Takahashi K; Ishikawa O
J Dermatol Sci; 2019 Oct; 96(1):18-25. PubMed ID: 31447183
[TBL] [Abstract][Full Text] [Related]
15. NECTIN4 promotes papillary thyroid cancer cell proliferation, migration, and invasion and triggers EMT by activating AKT.
Hao RT; Zheng C; Wu CY; Xia EJ; Zhou XF; Quan RD; Zhang XH
Cancer Manag Res; 2019; 11():2565-2578. PubMed ID: 31114323
[TBL] [Abstract][Full Text] [Related]
16. Cell-cell adhesion-mediated tyrosine phosphorylation of nectin-2delta, an immunoglobulin-like cell adhesion molecule at adherens junctions.
Kikyo M; Matozaki T; Kodama A; Kawabe H; Nakanishi H; Takai Y
Oncogene; 2000 Aug; 19(35):4022-8. PubMed ID: 10962558
[TBL] [Abstract][Full Text] [Related]
17. Vascular-targeted agents for the treatment of angiosarcoma.
Young RJ; Woll PJ; Staton CA; Reed MW; Brown NJ
Cancer Chemother Pharmacol; 2014 Feb; 73(2):259-70. PubMed ID: 24253175
[TBL] [Abstract][Full Text] [Related]
18. Activation of Cdc42 by trans interactions of the cell adhesion molecules nectins through c-Src and Cdc42-GEF FRG.
Fukuhara T; Shimizu K; Kawakatsu T; Fukuyama T; Minami Y; Honda T; Hoshino T; Yamada T; Ogita H; Okada M; Takai Y
J Cell Biol; 2004 Aug; 166(3):393-405. PubMed ID: 15277544
[TBL] [Abstract][Full Text] [Related]
19. Sporadic cutaneous angiosarcomas generally lack hypoxia-inducible factor 1alpha: a histologic and immunohistochemical study of 45 cases.
Abedalthagafi M; Rushing EJ; Auerbach A; Desouki MM; Marwaha J; Wang Z; Fanburg-Smith JC
Ann Diagn Pathol; 2010 Feb; 14(1):15-22. PubMed ID: 20123452
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a novel experimental model of human angiosarcoma and a VEGF-targeting therapeutic experiment.
Hoshina D; Abe R; Yoshioka N; Saito N; Hata H; Fujita Y; Aoyagi S; Shimizu H
J Dermatol Sci; 2013 May; 70(2):116-22. PubMed ID: 23522954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
